Flagellin suppresses epithelial apoptosis and limits disease during enteric infection

Matam Vijay-Kumar, Huixia Wu, Rupert Jones, George Grant, Brian Babbin, Timothy P King, Denise Kelly, Andrew T Gewirtz, Andrew S Neish

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Flagellin, the primary component of bacterial flagella, is a potent activator of toll-like receptor 5 (TLR5) signaling and is a major proinflammatory determinant of enteropathogenic Salmonella. In accordance with this, we report here that aflagellate Salmonella mutants are impaired in their ability to up-regulate proinflammatory and anti-apoptotic effector molecules in murine models of salmonellosis and that these mutants elicit markedly reduced early mucosal inflammation relative to their isogenic parent strains. Conversely, aflagellate bacteria were more potent activators of epithelial caspases and subsequent apoptosis. These phenomena correlated with a delayed but markedly exacerbated mucosal inflammation at the later stages of infection as well as elevated extra-intestinal and systemic bacterial load, culminating in a more severe clinical outcome. Systemic administration of exogenous flagellin primarily reversed the deleterious effects of in vivo Salmonella infection. These observations indicate that in Salmonella infection, flagellin plays a dominant role in activation of not only innate immunity but also anti-apoptotic processes in epithelial cells. These latter TLR-mediated responses that delay epithelial apoptosis may be as critical to mucosal defense as the classic acute inflammatory response. This notion is consistent with the emerging paradigm that specific TLR ligands may have a fundamental cytoprotective effect during inflammatory stress.
Original languageEnglish
Pages (from-to)1686-1700
Number of pages15
JournalAmerican Journal of Pathology
Volume169
Issue number5
DOIs
Publication statusPublished - 1 Nov 2006

Fingerprint

Flagellin
Salmonella Infections
Apoptosis
Salmonella
Toll-Like Receptor 5
Infection
Inflammation
Flagella
Bacterial Load
Caspases
Innate Immunity
Up-Regulation
Epithelial Cells
Ligands
Bacteria

Keywords

  • Animals
  • Apoptosis
  • Caco-2 Cells
  • Caspases
  • Cecum
  • Cell Survival
  • Cells, Cultured
  • Disease Models, Animal
  • Enteritis
  • Epithelial Cells
  • Female
  • Flagellin
  • Humans
  • Ileum
  • Inflammation
  • Intestinal Mucosa
  • Mice
  • Mice, Inbred BALB C
  • Rats
  • Salmonella
  • Salmonella Infections

Cite this

Vijay-Kumar, M., Wu, H., Jones, R., Grant, G., Babbin, B., King, T. P., ... Neish, A. S. (2006). Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. American Journal of Pathology, 169(5), 1686-1700. https://doi.org/10.2353/ajpath.2006.060345

Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. / Vijay-Kumar, Matam; Wu, Huixia; Jones, Rupert; Grant, George; Babbin, Brian; King, Timothy P; Kelly, Denise; Gewirtz, Andrew T; Neish, Andrew S.

In: American Journal of Pathology, Vol. 169, No. 5, 01.11.2006, p. 1686-1700.

Research output: Contribution to journalArticle

Vijay-Kumar, M, Wu, H, Jones, R, Grant, G, Babbin, B, King, TP, Kelly, D, Gewirtz, AT & Neish, AS 2006, 'Flagellin suppresses epithelial apoptosis and limits disease during enteric infection', American Journal of Pathology, vol. 169, no. 5, pp. 1686-1700. https://doi.org/10.2353/ajpath.2006.060345
Vijay-Kumar, Matam ; Wu, Huixia ; Jones, Rupert ; Grant, George ; Babbin, Brian ; King, Timothy P ; Kelly, Denise ; Gewirtz, Andrew T ; Neish, Andrew S. / Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. In: American Journal of Pathology. 2006 ; Vol. 169, No. 5. pp. 1686-1700.
@article{d03d400f215e4516b5564441df19e5eb,
title = "Flagellin suppresses epithelial apoptosis and limits disease during enteric infection",
abstract = "Flagellin, the primary component of bacterial flagella, is a potent activator of toll-like receptor 5 (TLR5) signaling and is a major proinflammatory determinant of enteropathogenic Salmonella. In accordance with this, we report here that aflagellate Salmonella mutants are impaired in their ability to up-regulate proinflammatory and anti-apoptotic effector molecules in murine models of salmonellosis and that these mutants elicit markedly reduced early mucosal inflammation relative to their isogenic parent strains. Conversely, aflagellate bacteria were more potent activators of epithelial caspases and subsequent apoptosis. These phenomena correlated with a delayed but markedly exacerbated mucosal inflammation at the later stages of infection as well as elevated extra-intestinal and systemic bacterial load, culminating in a more severe clinical outcome. Systemic administration of exogenous flagellin primarily reversed the deleterious effects of in vivo Salmonella infection. These observations indicate that in Salmonella infection, flagellin plays a dominant role in activation of not only innate immunity but also anti-apoptotic processes in epithelial cells. These latter TLR-mediated responses that delay epithelial apoptosis may be as critical to mucosal defense as the classic acute inflammatory response. This notion is consistent with the emerging paradigm that specific TLR ligands may have a fundamental cytoprotective effect during inflammatory stress.",
keywords = "Animals, Apoptosis, Caco-2 Cells, Caspases, Cecum, Cell Survival, Cells, Cultured, Disease Models, Animal, Enteritis, Epithelial Cells, Female, Flagellin, Humans, Ileum, Inflammation, Intestinal Mucosa, Mice, Mice, Inbred BALB C, Rats, Salmonella, Salmonella Infections",
author = "Matam Vijay-Kumar and Huixia Wu and Rupert Jones and George Grant and Brian Babbin and King, {Timothy P} and Denise Kelly and Gewirtz, {Andrew T} and Neish, {Andrew S}",
year = "2006",
month = "11",
day = "1",
doi = "10.2353/ajpath.2006.060345",
language = "English",
volume = "169",
pages = "1686--1700",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Flagellin suppresses epithelial apoptosis and limits disease during enteric infection

AU - Vijay-Kumar, Matam

AU - Wu, Huixia

AU - Jones, Rupert

AU - Grant, George

AU - Babbin, Brian

AU - King, Timothy P

AU - Kelly, Denise

AU - Gewirtz, Andrew T

AU - Neish, Andrew S

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Flagellin, the primary component of bacterial flagella, is a potent activator of toll-like receptor 5 (TLR5) signaling and is a major proinflammatory determinant of enteropathogenic Salmonella. In accordance with this, we report here that aflagellate Salmonella mutants are impaired in their ability to up-regulate proinflammatory and anti-apoptotic effector molecules in murine models of salmonellosis and that these mutants elicit markedly reduced early mucosal inflammation relative to their isogenic parent strains. Conversely, aflagellate bacteria were more potent activators of epithelial caspases and subsequent apoptosis. These phenomena correlated with a delayed but markedly exacerbated mucosal inflammation at the later stages of infection as well as elevated extra-intestinal and systemic bacterial load, culminating in a more severe clinical outcome. Systemic administration of exogenous flagellin primarily reversed the deleterious effects of in vivo Salmonella infection. These observations indicate that in Salmonella infection, flagellin plays a dominant role in activation of not only innate immunity but also anti-apoptotic processes in epithelial cells. These latter TLR-mediated responses that delay epithelial apoptosis may be as critical to mucosal defense as the classic acute inflammatory response. This notion is consistent with the emerging paradigm that specific TLR ligands may have a fundamental cytoprotective effect during inflammatory stress.

AB - Flagellin, the primary component of bacterial flagella, is a potent activator of toll-like receptor 5 (TLR5) signaling and is a major proinflammatory determinant of enteropathogenic Salmonella. In accordance with this, we report here that aflagellate Salmonella mutants are impaired in their ability to up-regulate proinflammatory and anti-apoptotic effector molecules in murine models of salmonellosis and that these mutants elicit markedly reduced early mucosal inflammation relative to their isogenic parent strains. Conversely, aflagellate bacteria were more potent activators of epithelial caspases and subsequent apoptosis. These phenomena correlated with a delayed but markedly exacerbated mucosal inflammation at the later stages of infection as well as elevated extra-intestinal and systemic bacterial load, culminating in a more severe clinical outcome. Systemic administration of exogenous flagellin primarily reversed the deleterious effects of in vivo Salmonella infection. These observations indicate that in Salmonella infection, flagellin plays a dominant role in activation of not only innate immunity but also anti-apoptotic processes in epithelial cells. These latter TLR-mediated responses that delay epithelial apoptosis may be as critical to mucosal defense as the classic acute inflammatory response. This notion is consistent with the emerging paradigm that specific TLR ligands may have a fundamental cytoprotective effect during inflammatory stress.

KW - Animals

KW - Apoptosis

KW - Caco-2 Cells

KW - Caspases

KW - Cecum

KW - Cell Survival

KW - Cells, Cultured

KW - Disease Models, Animal

KW - Enteritis

KW - Epithelial Cells

KW - Female

KW - Flagellin

KW - Humans

KW - Ileum

KW - Inflammation

KW - Intestinal Mucosa

KW - Mice

KW - Mice, Inbred BALB C

KW - Rats

KW - Salmonella

KW - Salmonella Infections

U2 - 10.2353/ajpath.2006.060345

DO - 10.2353/ajpath.2006.060345

M3 - Article

VL - 169

SP - 1686

EP - 1700

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -